This week in M&A. Imprivata, a tech company providing identity and authentication tools designed specifically for healthcare, has acquired GroundControl Solutions, inc., which is known for its automated enterprise mobile device management software. Imprivata anticipates that the purchase of this new tech will augment its platform with new capabilities for large and small healthcare...
A collection of more than 50 LGBTQ, public health and HIV/AIDS activists have signed a joint letter urging Facebook to remove advertisements from its platform that they say are “factually inaccurate” and scare at-risk users away from pre-exposure prophylaxis (PrEP) treatments.
These ads — which the signatory groups say are being directed at LGBTQ Facebook and Instagram users — come from multiple...
HIV patients demonstrated greater adherence to their antiretroviral therapy (ART) following the use of a low-cost educational VR application, according to a new study published in the Interactive Journal of Medical Research.
Delivered in English and Spanish on a Dell Windows Mixed Reality headset, the seven-minute experience consisted of an interactive look at the cells and pathogens of a virtual...
Department of Veteran Affairs clinics that offered HIV patients telehealth programs found modest improvements in population-level viral suppression despite a low utilization rate of roughly one in eight patients, according to a study published last month in Open Forum Infectious Diseases.
“Our findings describe the impact of HIV telehealth programs implemented as quality improvement programs in...
A new study conducted at Brigham and Women’s Hospital in Boston in partnership with The Fenway Institute at Fenway Health will be using eTectRx’s ingestion event monitoring system to research adherence of the HIV prevention drug Truvada for pre-exposure prophylaxis (PrEP).
PrEP is a preventative drug designed to be taken by people who do not have HIV but are at risk for the condition. and must...
De Novo rule proposal published for review. The FDA has published a new proposal for revisions to the De Novo regulatory pathway for devices without a predicate. The rule, which is currently available for public comment, aims to provide additional structure, clarity and transparency to the process, and outlines how the agency processes and gauges submitted devices.
“Our goal is to make the De...
Proteus Digital Health’ pitch to track adherence using sensor-equipped pills has found another audience in the HIV prevention community.
Among the featured data presented at this week’s International AIDS Conference in Amsterdam was a trial that outfitted Gilead Sciences’ preventive HIV drug Truvada (tenofovir/emtricitabine) with the tracking technology. Here, researchers found that the sensor-...
Correction: A previous version of this article misstated that ACE was the name of the mobile app. ACE is the name of PharMedQuest's customer relationship management platform and not the mobile app.
Healthcare management company PharMedQuest announced last week that it has made a strategic investment in helparound, an Israeli company which makes an app that supports and connects patients with...
Researchers at Portland State University have teamed up with Oakland, California-based dfusion, a health tech startup focused on behavior change research, to develop a mobile app for HIV prevention among transgender women.
The app, which will be called Transwomen Connected, will also be designed as a resource for transgender women to speak with a network of supportive peers. The project is funded...
It seems counterintuitive for those who proudly wear the "hacker" label to seek ways to work with established industry players rather than being disruptive in a healthcare sector badly in need of radical change, but that was what happened at Health and Wellness Innovation 2013, the recently concluded 11-day event better known as MIT Media Lab's Health and Wellness Hackathon.
The hackathon brought...
